Fresenius SE & Co. KGaA

Company Overview

Fresenius SE & Co. KGaA is a global healthcare company providing essential products and services for leading therapies for critically and chronically ill patients. It operates through three business segments: Fresenius Kabi, Fresenius Helios, and Other. It operates in more than 60 countries through its subsidiaries, with primary markets in Europe and North America. It maintains an international distribution network and has over 50 production sites.

Fresenius caters to the infusion pump and device market through the Fresenius Kabi business. It specializes in products for treating and caring for critically and chronically ill patients.

Financial Highlights (FY 2025)

Company's Business Segments

• Fresenius Kabi : This segment includes biopharmaceuticals, clinical nutrition, MedTech products, intravenously administered generic drugs (generic IV drugs), and IV fluids.
• Fresenius Helios : It is Europe’s leading private healthcare service provider, and its portfolio includes Helios Germany, Helios Spain, and Eugin Group (which was sold on January 31, 2024).
• Fresenius Vamed : This segment manages projects and provides services for hospitals and other healthcare facilities internationally. The services cover the entire value chain, from development, planning, and turnkey construction to maintenance, technical management, total operational management, and higher services.